about
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that...
Read More
28.00
-0.83
(-2.88%)
509.3K
XNAS Volume
XNAS 26 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Upstream Bio Inc. is on 28 Nov 2025 for the purpose of Upstream Bio Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Upstream Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..